We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCNE icon
5026
CNB Financial Corp
CCNE
$1.04B
$5K ﹤0.01%
191
-103
-35% -$2.76K
CEF icon
5027
Sprott Physical Gold and Silver Trust
CEF
$8.27B
$5K ﹤0.01%
264
– –
CKPT
5028
DELISTED
Checkpoint Therapeutics
CKPT
$5K ﹤0.01%
+286
New +$6.14K
CMT icon
5029
Core Molding Technologies
CMT
$229M
$5K ﹤0.01%
457
-387
-46% -$3.54K
PRHI
5030
Presurance Holdings
PRHI
$20.2M
$5K ﹤0.01%
274
-196
-42% -$3.22K
COCP icon
5031
Cocrystal Pharma
COCP
$14.8M
$5K ﹤0.01%
+701
New +$4.66K
COHN icon
5032
Cohen & Co
COHN
$38.7M
$5K ﹤0.01%
303
-165
-35% -$2.5K
CRBP icon
5033
Corbus Pharmaceuticals
CRBP
$193M
$5K ﹤0.01%
303
+217
+252% +$2.88K
CRVS icon
5034
Corvus Pharmaceuticals
CRVS
$1.26B
$5K ﹤0.01%
2,972
-14,592
-83% -$26.7K
CULP icon
5035
Culp Inc
CULP
$43.3M
$5K ﹤0.01%
652
-1,554
-70% -$13.2K
DBJP icon
5036
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$726M
$5K ﹤0.01%
100
– –
DMAC icon
5037
DiaMedica Therapeutics
DMAC
$362M
$5K ﹤0.01%
1,668
-7,692
-82% -$21.8K
ELDN icon
5038
Eledon Pharmaceuticals
ELDN
$279M
$5K ﹤0.01%
1,326
-730
-36% -$2.83K
ELEV
5039
DELISTED
Elevation Oncology
ELEV
$5K ﹤0.01%
2,055
+1,060
+107% +$4.25K
ESP icon
5040
Espey Mfg & Electronics Corp
ESP
$194M
$5K ﹤0.01%
357
-31
-8% -$412
ESQ icon
5041
Esquire Financial Holdings
ESQ
$1.58B
$5K ﹤0.01%
135
-155
-53% -$5.2K
EVOK
5042
DELISTED
Evoke Pharma
EVOK
$5K ﹤0.01%
75
+46
+159% +$3.67K
EWJV icon
5043
iShares MSCI Japan Value ETF
EWJV
$756M
$5K ﹤0.01%
+200
New +$5.44K
FDL icon
5044
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.98B
$5K ﹤0.01%
134
– –
FINX icon
5045
Global X FinTech ETF
FINX
$171M
$5K ﹤0.01%
160
-531
-77% -$17.4K
FONR
5046
DELISTED
Fonar
FONR
$5K ﹤0.01%
+251
New +$4.2K
GHYB icon
5047
Goldman Sachs Access High Yield Corporate Bond ETF
GHYB
$134M
$5K ﹤0.01%
+100
New +$4.78K
GIGM icon
5048
GigaMedia
GIGM
$16.6M
$5K ﹤0.01%
2,594
+1,861
+254% +$3.69K
GLDM icon
5049
SPDR Gold MiniShares Trust
GLDM
$30.1B
$5K ﹤0.01%
127
-291
-70% -$10.9K
GNFT
5050
DELISTED
Genfit
GNFT
$5K ﹤0.01%
+1,260
New +$5.15K
200 201
202
203 204

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.